We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

115 hedge funds and large institutions have $495M invested in IVERIC bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $5.48M | Put options by funds: $2.34M

55% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 29

4% less funds holding

Funds holding: 120115 (-5)

9% less capital invested

Capital invested by funds: $542M → $495M (-$46.5M)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
115
Holders Change
-5
Holders Change %
-4.17%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
11
Increased
45
Reduced
29
Closed
16
Calls
$5.48M
Puts
$2.34M
Net Calls
+$3.14M
Net Calls Change
-$3.62M
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Nuveen
North Carolina
$4.77M -$1.45M -238,354 -24%
OCA
27
Octagon Capital Advisors
New York
$4.2M
TA
28
Tamarack Advisers
California
$3.55M -$1.67M -275,000 -32%
Deutsche Bank
29
Deutsche Bank
Germany
$2.76M -$1.22M -201,742 -31%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.12M +$2.82K +465 +0.1%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$1.67M -$59.4K -9,783 -3%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$1.51M +$332K +54,700 +29%
First Trust Advisors
33
First Trust Advisors
Illinois
$1.35M +$107K +17,588 +9%
Charles Schwab
34
Charles Schwab
California
$1.27M +$31.2K +5,137 +3%
Citigroup
35
Citigroup
New York
$1.23M +$947K +156,040 +361%
Two Sigma Investments
36
Two Sigma Investments
New York
$1.16M +$1.07M +176,753 +1,669%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.01M
AA
38
ALPS Advisors
Colorado
$1.01M +$7.98K +1,315 +0.8%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1M
Rafferty Asset Management
40
Rafferty Asset Management
New York
$974K +$774K +127,578 +424%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$962K +$221K +36,455 +31%
PAWC
42
P.A.W. Capital
Connecticut
$927K +$911K +150,000 New
CC
43
Caxton Corporation
New Jersey
$911K +$75.2K +12,385 +9%
HS
44
HighVista Strategies
Massachusetts
$872K +$146K +23,995 +20%
SCM
45
Silverarc Capital Management
Massachusetts
$804K
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$751K
MPAM
47
Monarch Partners Asset Management
Massachusetts
$742K +$185K +30,410 +34%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$718K -$44K -7,250 -6%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$700K
Squarepoint
50
Squarepoint
New York
$589K +$228K +37,481 +65%

ISEE Hedge Fund Activity: Q1 2021 in Review

115 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2021, worth a combined $495M — down 8.6% from $542M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ISEE and 11 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 45 added.

The largest buyer was Yiheng Capital Management, adding an estimated $15.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $16.4M sold.

  • 115 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2021, down from 120 in Q4 2020.
  • Funds reported $495M of IVERIC bio, Inc. Common Stock stock for Q1 2021, down 8.6% quarter-over-quarter.
  • 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2021 and 16 closed out, a net change of -5 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q1 2021 was Yiheng Capital Management, an estimated $15.9M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q1 2021 was Consonance Capital Management, an estimated $16.4M sold.

Based on aggregated 13F filings for Q1 2021.